TRAW — TRAWS PHARMA INC

Ownership history in XTX Topco Ltd  ·  2 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in TRAWS PHARMA INC (TRAW). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 42,210 +31,502 +294.2% 0.00% $48K $1.13
2025 Q3 INITIATED 10,708 — — 0.00% $20K $1.85
% of Fund (quarterly)    TRAW price (monthly, adj. close)

Other funds also holding TRAW

As of 2025 Q4 — sorted by position size

Ikarian Capital, LLC 3Y 0.06% Seven Fleet Capital Management LP 0.04% ORBIMED ADVISORS LLC 3Y 7Y 0.01% ADAR1 Capital Management, LLC 0.01% BOOTHBAY FUND MANAGEMENT, LLC 3Y 7Y 0.0% ADAGE CAPITAL PARTNERS GP, L.L.C. 3Y 7Y 0.0% TWO SIGMA INVESTMENTS, LP 3Y 7Y 0.0% GEODE CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0% CITADEL ADVISORS LLC 3Y 7Y 0.0% SUSQUEHANNA INTERNATIONAL GROUP, LLP 3Y 7Y 0.0%
← Back to XTX Topco Ltd Holdings